FindTrial
Sign In

A study on preventive action of Ayurvedic medicine in Covid 19.

A Randomized Comparative Open-Ended Clinical Study to Evaluate the Role of Matulungadi nasya in the Prophylaxis of COVID-19 Disease w.s.r to youngsters

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040266
Enrollment
100
Registered
2022-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Pappiniseeri Visha Chikitsa Kendram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers (status of health will be assessed as per Ayurvedic criteria of swasthya) Young subjects who have high chances exposure to Covid-19cases Those with negative (non reactive) SARS Covid-19 on RTPCR Who are ready to participate and give informed consent •Age group of 18 to 30 irrespective of sex

Exclusion criteria

Exclusion criteria: Those suffering with immune compromised conditions Those suffering with serious systemic illness If the co morbidity are present Those with positive ( reactive) test result on rapid antibody test for SARS Covid-19 or RTPCR

Design outcomes

Primary

MeasureTime frame
negative RTPCRTimepoint: six weeks—

Secondary

MeasureTime frame
non appearance of covid symptomsTimepoint: six weeks—

Countries

India

Contacts

Public ContactDr Shyam Prasad M

Parassinikkadavu Ayurveda medical college

getshyampm@yahoo.co.in9496192409

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026